Change Language

Select Language

India Implantable Medical Devices Market to Reach US$ 142.0 Billion by 2027, Spurred by Increasing Prevalence of Chronic Diseases

Published on Sep 30, 2022

The latest report by IMARC Group, titled “India Implantable Medical Devices Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” finds that the India implantable medical devices market size reached US$ 94.8 Billion in 2021. Implantable medical devices are employed for diagnostic and therapeutic purposes, such as replacing damaged body organs and monitoring the functions of different organs and tissues. Some commonly implantable medical devices include contraceptive intra-uterine devices (IUDs), artificial joints, breast implants, and bone, muscle, and joint fusion hardware, and implanted vascular access devices. They are used in patients with poor peripheral venous access or who require frequent vein access for treatments like chemotherapy. These devices are implanted into the body through surgical procedures and can be removed later as per the requirement. They are generally made using ceramics, metals, body tissues, and plastics that help enhance the quality of the patient’s life. Nowadays, the growing incidences of chronic diseases and the rising awareness about healthcare devices are positively influencing the demand for implantable medical devices in India.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

India Implantable Medical Devices Market Trends:

The market is primarily driven by the increasing prevalence of chronic diseases among individuals. In addition, the growing geriatric population, which is more susceptible to critical medical ailments, is contributing to market growth. Moreover, the rising awareness regarding the accessibility of implantable devices and the availability of advanced healthcare infrastructure represents another major growth-inducing factor. Apart from this, various technological advancements and the extensive integration of modern technologies in the healthcare sector are providing a positive thrust to market growth. Along with this,  professionals are widely adopting miniaturized implantable medical devices. This, coupled with the increasing number of cosmetic surgeries due to the rising preference for maintaining an aesthetic appearance among the masses, is augmenting the market growth. Other factors, including rapid urbanization, inflating disposable income levels of the masses, extensive research and development (R&D) activities conducted by key players, and rising investments by private and public firms to upgrade the existing healthcare infrastructure, are also creating a positive market outlook across the country. Looking forward, IMARC Group expects the market value to reach US$ 142.0 Billion by 2027, exhibiting a CAGR of 6.87% during the forecast period (2022-2027).

Market Summary:

  • Based on the product, the market has been classified into orthopedic, dental, facial, breast, cardiovascular, and other implants.
  • On the basis of the material, the market has been segmented into polymers, metals, ceramics, and biologics.
  • Based on the end user, the market has been divided into hospitals, ambulatory surgery centers (ASCs), and clinics.
  • On the geographical front, the market has been divided into North India, West and Central India, South India, and East India.
  • The competitive landscape of the market has been examined in the report, with detailed profiles of key players operating in the industry.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800


Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )

Drop us an email at